Skip to main content
Fig. 3 | BMC Gastroenterology

Fig. 3

From: HLA class II donor specific antibodies are associated with graft cirrhosis after liver transplant independent of the mean fluorescence intensity level

Fig. 3

Mean fluorescence intensity levels according to presence of posttransplant complications, according to HLA class, and according to presence of donor-specific antibodies. a Occurrence of complications in association with mean fluorescence intensity (MFI) levels. b Correlation between HLA classes and MFI levels. Average MFI levels for patients with detectable HLA-I donor-specific antibodies (DSA were lower than 5000; those for patients with detectable HLA-II DSA were approximately 5000 and those for patients testing positive for both HLA-I and HLA-II DSA were higher than 10,000 (P = 0.005). c Prevalence of complications in association with HLA classes and MFI levels. Within the various HLA classes there were no significant differences in MFI levels between liver transplant patients with and without complications. DSA, donor-specific antibody; HLA, human leukocyte antigen

Back to article page

BMC Gastroenterology

ISSN: 1471-230X

Contact us